Antiendotoxin Strategies for the Prevention and Treatment of Septic Shock
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 55 (4) , 497-508
- https://doi.org/10.2165/00003495-199855040-00002
Abstract
Therapy for Gram-negative sepsis remains unsatisfactory despite a concerted effort to develop new treatments for this common, life-threatening syndrome. Current research continues on several fronts...Keywords
This publication has 69 references indexed in Scilit:
- Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic ShockThe Journal of Infectious Diseases, 1996
- Resistance to Endotoxin Shock and Reduced Dissemination of Gram-Negative Bacteria in CD14-Deficient MiceImmunity, 1996
- Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing ProteinThe Journal of Infectious Diseases, 1995
- Repression of lipopolysaccharide biosynthesis in Escherichia coli by an antisense RNA of Acetobacter methanolicus phage Acm1Molecular Microbiology, 1995
- Extracorporeal Endotoxin Removal in a Canine Model of Septic ShockAsaio Journal, 1994
- Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.The Journal of Experimental Medicine, 1993
- Lipopolysaccharide antagonistsImmunology Today, 1992
- Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing proteinInflammation Research, 1991
- Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.The Journal of Experimental Medicine, 1990
- Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4European Journal of Biochemistry, 1989